Clinical Trials Directory

Trials / Completed

CompletedNCT06598566

A Comparative Evaluation of Nottingham Hip Fracture Score (NHFS) and Acute Physiology and Chronic Health Evaluation (APACHE) II Score to Predict 30-day Mortality in Geriatric Patients Above 60 Years Undergoing Hip Fracture Surgery.

Status
Completed
Phase
Study type
Observational
Enrollment
182 (actual)
Sponsor
Tata Main Hospital · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years old undergoing hip fracture surgery.

Detailed description

The study aim to compare the Nottingham Hip Fracture Score (NHFS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score in predicting 30-day mortality in geriatric patients over 60 years undergoing hip fracture surgery. This study was conducted at the Tata Main Hospital in Jamshedpur, India. The study was designed as a prospective observational study, with data collected from June 2022 to June 2023. The study's primary objective was to predict mortality in patients undergoing hip fracture surgery. The study also investigated secondary outcomes such as the need for postoperative ventilator and ionotropic support, the occurrence of acute kidney injury, cardiac morbidity, and the presence of pulmonary embolism and deep vein thrombosis, as well as length of stay.

Conditions

Interventions

TypeNameDescription
OTHERNottingham Hip Fracture Score (NHFS) scoreNottingham Hip Fracture Score (NHFS) score in patients above 60 years undergoing hip fracture surgery.
OTHERAcute Physiology and Chronic Health Evaluation (APACHE)-II scoreAcute Physiology and Chronic Health Evaluation (APACHE)-II score in patients above 60 years undergoing hip fracture surgery

Timeline

Start date
2022-06-20
Primary completion
2023-06-19
Completion
2023-06-19
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06598566. Inclusion in this directory is not an endorsement.